ArticleTrends in endocrinology and metabolism: TEM2018

GABAergic Signaling Mediates Central Cardiovascular Angiotensin II Type 2 Receptor Effects.

Laura Légat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.